The Angiogenesis Foundation Explained

The Angiogenesis Foundation
Type:Non-profit
Foundation:1994 in Cambridge, MA
Founder:William W. Li, MD and Vincent W. Li, MD (co-founders)
Location:Cambridge, MA, U.S.
Homepage:angio.org

The Angiogenesis Foundation, is a United States 501(c)(3) nonprofit organization established in 1994 for the study of angiogenesis. The foundation developed a therapy for canine cancer, called the Navy Protocol. This treatment works by starving the tumor of its blood supply.[1] In 2004, they helped publicly launch the first antiangiogenic therapy for cancer, bevacizumab, starting with colorectal cancer.[2]

Co-founder Dr. William Li won the 2024 Dr. Andrew von Eschenbach Award for his work in angiogenesis.[3]

External links

Notes and References

  1. https://web.archive.org/web/20060220215948/https://www.usatoday.com/news/health/2002-07-24-cover-cancer_x.htm Dog's tale of survival opens door in cancer research, July 24, 2002
  2. https://web.archive.org/web/20040605075232/http://www.boston.com/news/local/massachusetts/articles/2004/02/26/colon_cancer_drug_seen_as_long_awaited_victory/ Colon cancer drug seen as long awaited victory, February 26, 2004
  3. https://www.stemcellsciencenews.com/newsletter/220856/ The Angiogenesis Foundation Chief Executive Officer Dr. William Li Was Honored As the Inaugural Recipient of the Dr. Andrew Von Eschenbach Award

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "The Angiogenesis Foundation".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.